McConkey DJ - Search Results

1

Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.

Pino MS, Nawrocki ST, Cognetti F, Abruzzese JL, Xiong HQ, McConkey DJ. Pino MS, et al. Among authors: mcconkey dj. Cancer Biol Ther. 2005 Nov;4(11):1263-9. doi: 10.4161/cbt.4.11.2138. Epub 2005 Dec 1. Cancer Biol Ther. 2005. PMID: 16319525 Free article.

2

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.

Raut CP, Nawrocki S, Lashinger LM, Davis DW, Khanbolooki S, Xiong H, Ellis LM, McConkey DJ. Raut CP, et al. Among authors: mcconkey dj. Cancer Biol Ther. 2004 Dec;3(12):1217-24. doi: 10.4161/cbt.3.12.1221. Epub 2004 Dec 9. Cancer Biol Ther. 2004. PMID: 15477758 Free article.

3

Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.

Pino MS, Shrader M, Baker CH, Cognetti F, Xiong HQ, Abbruzzese JL, McConkey DJ. Pino MS, et al. Among authors: mcconkey dj. Cancer Res. 2006 Apr 1;66(7):3802-12. doi: 10.1158/0008-5472.CAN-05-3753. Cancer Res. 2006. PMID: 16585207

4

Velcade displays promising activity in primary effusion lymphoma cells.

McConkey D, Nawrocki ST, Andtbacka R. McConkey D, et al. Cancer Biol Ther. 2005 Apr;4(4):491-2. doi: 10.4161/cbt.4.4.1645. Epub 2005 Apr 28. Cancer Biol Ther. 2005. PMID: 15908793 Free article. No abstract available.

5

Novel therapies for pancreatic adenocarcinoma.

Pino SM, Xiong HQ, McConkey D, Abbruzzese JL. Pino SM, et al. Curr Oncol Rep. 2004 May;6(3):199-206. doi: 10.1007/s11912-004-0050-1. Curr Oncol Rep. 2004. PMID: 15066231 Review.

6

The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts.

Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ. Nawrocki ST, et al. Among authors: mcconkey dj. Mol Cancer Ther. 2004 Jan;3(1):59-70. Mol Cancer Ther. 2004. PMID: 14749476

7

Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.

Nawrocki ST, Carew JS, Dunner K Jr, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, McConkey DJ. Nawrocki ST, et al. Among authors: mcconkey dj. Cancer Res. 2005 Dec 15;65(24):11510-9. doi: 10.1158/0008-5472.CAN-05-2394. Cancer Res. 2005. PMID: 16357160

8

Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis.

Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Dunner K Jr, Huang P, Abbruzzese JL, McConkey DJ. Nawrocki ST, et al. Among authors: mcconkey dj. Cancer Res. 2005 Dec 15;65(24):11658-66. doi: 10.1158/0008-5472.CAN-05-2370. Cancer Res. 2005. PMID: 16357177

9

Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K Jr, Pal A, Bornmann WG, Chiao PJ, Huang P, Xiong H, Abbruzzese JL, McConkey DJ. Nawrocki ST, et al. Among authors: mcconkey dj. Cancer Res. 2006 Apr 1;66(7):3773-81. doi: 10.1158/0008-5472.CAN-05-2961. Cancer Res. 2006. PMID: 16585204

10

Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.

Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ. Khanbolooki S, et al. Among authors: mcconkey dj. Mol Cancer Ther. 2006 Sep;5(9):2251-60. doi: 10.1158/1535-7163.MCT-06-0075. Mol Cancer Ther. 2006. PMID: 16985059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters